 | • レポートコード：QFJ1-6038 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、血栓溶解薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（フィブリン特異的薬物、非フィブリン特異的薬物）、用途別市場規模（病院薬局、小売薬局、電子薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・血栓溶解薬の市場動向 ・企業の競争状況、市場シェア ・血栓溶解薬の種類別市場規模と予測2016-2027（フィブリン特異的薬物、非フィブリン特異的薬物） ・血栓溶解薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、電子薬局） ・血栓溶解薬の北米市場規模2016-2027（アメリカ、カナダ） ・血栓溶解薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・血栓溶解薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・血栓溶解薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・血栓溶解薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Sedico Pharmaceuticals、Eumedica、Genentech、Microbix、Medac、Mochida Pharmaceutical、Taj Pharmaceuticals、Wulfing Pharma GmbH） ・結論 |
Thrombolytic drugs, which dissolve solid blood clots, are commonly used to treat clot complications such as acute myocardial infarction, pulmonary embolism, deep venous thrombosis, blocked catheters, and acute ischemic stroke.Urokinase, streptokinase and tissue plasminogen activator (tPA) are the basic thrombolytic agents available on the market for thrombolytic therapy.Divided into fibrin – specific drugs and non – fibrin – specific drugs.The fibrin-specific drug segment is further divided into tissue plasminogen activator, retiplase, tenaiplase, etc.Nonfibrin-specific drugs are subdivided into urokinase, streptokinase, and plasminogen activated complexes.
Market Analysis and Insights: Global Thrombolytic Drug Market
The global Thrombolytic Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Thrombolytic Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Thrombolytic Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Thrombolytic Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Thrombolytic Drug market.
Global Thrombolytic Drug Scope and Market Size
Thrombolytic Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Thrombolytic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Fibrin Specific Drugs
Nonfibrin-specific Drugs
Segment by Application
Hospital Pharmacy
Retail Pharmacies
Electronic Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Sedico Pharmaceuticals
Eumedica
Genentech
Microbix
Medac
Mochida Pharmaceutical
Taj Pharmaceuticals
Wulfing Pharma GmbH
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Thrombolytic Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fibrin Specific Drugs
1.2.3 Nonfibrin-specific Drugs
1.3 Market by Application
1.3.1 Global Thrombolytic Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacies
1.3.4 Electronic Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Thrombolytic Drug Market Perspective (2016-2027)
2.2 Thrombolytic Drug Growth Trends by Regions
2.2.1 Thrombolytic Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Thrombolytic Drug Historic Market Share by Regions (2016-2021)
2.2.3 Thrombolytic Drug Forecasted Market Size by Regions (2022-2027)
2.3 Thrombolytic Drug Industry Dynamic
2.3.1 Thrombolytic Drug Market Trends
2.3.2 Thrombolytic Drug Market Drivers
2.3.3 Thrombolytic Drug Market Challenges
2.3.4 Thrombolytic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Thrombolytic Drug Players by Revenue
3.1.1 Global Top Thrombolytic Drug Players by Revenue (2016-2021)
3.1.2 Global Thrombolytic Drug Revenue Market Share by Players (2016-2021)
3.2 Global Thrombolytic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Thrombolytic Drug Revenue
3.4 Global Thrombolytic Drug Market Concentration Ratio
3.4.1 Global Thrombolytic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Thrombolytic Drug Revenue in 2020
3.5 Thrombolytic Drug Key Players Head office and Area Served
3.6 Key Players Thrombolytic Drug Product Solution and Service
3.7 Date of Enter into Thrombolytic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Thrombolytic Drug Breakdown Data by Type
4.1 Global Thrombolytic Drug Historic Market Size by Type (2016-2021)
4.2 Global Thrombolytic Drug Forecasted Market Size by Type (2022-2027)
5 Thrombolytic Drug Breakdown Data by Application
5.1 Global Thrombolytic Drug Historic Market Size by Application (2016-2021)
5.2 Global Thrombolytic Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Thrombolytic Drug Market Size (2016-2027)
6.2 North America Thrombolytic Drug Market Size by Type
6.2.1 North America Thrombolytic Drug Market Size by Type (2016-2021)
6.2.2 North America Thrombolytic Drug Market Size by Type (2022-2027)
6.2.3 North America Thrombolytic Drug Market Size by Type (2016-2027)
6.3 North America Thrombolytic Drug Market Size by Application
6.3.1 North America Thrombolytic Drug Market Size by Application (2016-2021)
6.3.2 North America Thrombolytic Drug Market Size by Application (2022-2027)
6.3.3 North America Thrombolytic Drug Market Size by Application (2016-2027)
6.4 North America Thrombolytic Drug Market Size by Country
6.4.1 North America Thrombolytic Drug Market Size by Country (2016-2021)
6.4.2 North America Thrombolytic Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Thrombolytic Drug Market Size (2016-2027)
7.2 Europe Thrombolytic Drug Market Size by Type
7.2.1 Europe Thrombolytic Drug Market Size by Type (2016-2021)
7.2.2 Europe Thrombolytic Drug Market Size by Type (2022-2027)
7.2.3 Europe Thrombolytic Drug Market Size by Type (2016-2027)
7.3 Europe Thrombolytic Drug Market Size by Application
7.3.1 Europe Thrombolytic Drug Market Size by Application (2016-2021)
7.3.2 Europe Thrombolytic Drug Market Size by Application (2022-2027)
7.3.3 Europe Thrombolytic Drug Market Size by Application (2016-2027)
7.4 Europe Thrombolytic Drug Market Size by Country
7.4.1 Europe Thrombolytic Drug Market Size by Country (2016-2021)
7.4.2 Europe Thrombolytic Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Thrombolytic Drug Market Size (2016-2027)
8.2 Asia-Pacific Thrombolytic Drug Market Size by Type
8.2.1 Asia-Pacific Thrombolytic Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Thrombolytic Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Thrombolytic Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Thrombolytic Drug Market Size by Application
8.3.1 Asia-Pacific Thrombolytic Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Thrombolytic Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Thrombolytic Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Thrombolytic Drug Market Size by Region
8.4.1 Asia-Pacific Thrombolytic Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Thrombolytic Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Thrombolytic Drug Market Size (2016-2027)
9.2 Latin America Thrombolytic Drug Market Size by Type
9.2.1 Latin America Thrombolytic Drug Market Size by Type (2016-2021)
9.2.2 Latin America Thrombolytic Drug Market Size by Type (2022-2027)
9.2.3 Latin America Thrombolytic Drug Market Size by Type (2016-2027)
9.3 Latin America Thrombolytic Drug Market Size by Application
9.3.1 Latin America Thrombolytic Drug Market Size by Application (2016-2021)
9.3.2 Latin America Thrombolytic Drug Market Size by Application (2022-2027)
9.3.3 Latin America Thrombolytic Drug Market Size by Application (2016-2027)
9.4 Latin America Thrombolytic Drug Market Size by Country
9.4.1 Latin America Thrombolytic Drug Market Size by Country (2016-2021)
9.4.2 Latin America Thrombolytic Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Thrombolytic Drug Market Size (2016-2027)
10.2 Middle East & Africa Thrombolytic Drug Market Size by Type
10.2.1 Middle East & Africa Thrombolytic Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Thrombolytic Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Thrombolytic Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Thrombolytic Drug Market Size by Application
10.3.1 Middle East & Africa Thrombolytic Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Thrombolytic Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Thrombolytic Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Thrombolytic Drug Market Size by Country
10.4.1 Middle East & Africa Thrombolytic Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Thrombolytic Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Thrombolytic Drug Introduction
11.1.4 Roche Revenue in Thrombolytic Drug Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Sedico Pharmaceuticals
11.2.1 Sedico Pharmaceuticals Company Details
11.2.2 Sedico Pharmaceuticals Business Overview
11.2.3 Sedico Pharmaceuticals Thrombolytic Drug Introduction
11.2.4 Sedico Pharmaceuticals Revenue in Thrombolytic Drug Business (2016-2021)
11.2.5 Sedico Pharmaceuticals Recent Development
11.3 Eumedica
11.3.1 Eumedica Company Details
11.3.2 Eumedica Business Overview
11.3.3 Eumedica Thrombolytic Drug Introduction
11.3.4 Eumedica Revenue in Thrombolytic Drug Business (2016-2021)
11.3.5 Eumedica Recent Development
11.4 Genentech
11.4.1 Genentech Company Details
11.4.2 Genentech Business Overview
11.4.3 Genentech Thrombolytic Drug Introduction
11.4.4 Genentech Revenue in Thrombolytic Drug Business (2016-2021)
11.4.5 Genentech Recent Development
11.5 Microbix
11.5.1 Microbix Company Details
11.5.2 Microbix Business Overview
11.5.3 Microbix Thrombolytic Drug Introduction
11.5.4 Microbix Revenue in Thrombolytic Drug Business (2016-2021)
11.5.5 Microbix Recent Development
11.6 Medac
11.6.1 Medac Company Details
11.6.2 Medac Business Overview
11.6.3 Medac Thrombolytic Drug Introduction
11.6.4 Medac Revenue in Thrombolytic Drug Business (2016-2021)
11.6.5 Medac Recent Development
11.7 Mochida Pharmaceutical
11.7.1 Mochida Pharmaceutical Company Details
11.7.2 Mochida Pharmaceutical Business Overview
11.7.3 Mochida Pharmaceutical Thrombolytic Drug Introduction
11.7.4 Mochida Pharmaceutical Revenue in Thrombolytic Drug Business (2016-2021)
11.7.5 Mochida Pharmaceutical Recent Development
11.8 Taj Pharmaceuticals
11.8.1 Taj Pharmaceuticals Company Details
11.8.2 Taj Pharmaceuticals Business Overview
11.8.3 Taj Pharmaceuticals Thrombolytic Drug Introduction
11.8.4 Taj Pharmaceuticals Revenue in Thrombolytic Drug Business (2016-2021)
11.8.5 Taj Pharmaceuticals Recent Development
11.9 Wulfing Pharma GmbH
11.9.1 Wulfing Pharma GmbH Company Details
11.9.2 Wulfing Pharma GmbH Business Overview
11.9.3 Wulfing Pharma GmbH Thrombolytic Drug Introduction
11.9.4 Wulfing Pharma GmbH Revenue in Thrombolytic Drug Business (2016-2021)
11.9.5 Wulfing Pharma GmbH Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Thrombolytic Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fibrin Specific Drugs
Table 3. Key Players of Nonfibrin-specific Drugs
Table 4. Global Thrombolytic Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Thrombolytic Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Thrombolytic Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Thrombolytic Drug Market Share by Regions (2016-2021)
Table 8. Global Thrombolytic Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Thrombolytic Drug Market Share by Regions (2022-2027)
Table 10. Thrombolytic Drug Market Trends
Table 11. Thrombolytic Drug Market Drivers
Table 12. Thrombolytic Drug Market Challenges
Table 13. Thrombolytic Drug Market Restraints
Table 14. Global Thrombolytic Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Thrombolytic Drug Market Share by Players (2016-2021)
Table 16. Global Top Thrombolytic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thrombolytic Drug as of 2020)
Table 17. Ranking of Global Top Thrombolytic Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Thrombolytic Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Thrombolytic Drug Product Solution and Service
Table 21. Date of Enter into Thrombolytic Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Thrombolytic Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Thrombolytic Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Thrombolytic Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Thrombolytic Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Thrombolytic Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Thrombolytic Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Thrombolytic Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Thrombolytic Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Thrombolytic Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Thrombolytic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Thrombolytic Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Thrombolytic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Thrombolytic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Thrombolytic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Thrombolytic Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Thrombolytic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Thrombolytic Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Thrombolytic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Thrombolytic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Thrombolytic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Thrombolytic Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Thrombolytic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Thrombolytic Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Thrombolytic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Thrombolytic Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Thrombolytic Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Thrombolytic Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Thrombolytic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Thrombolytic Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Thrombolytic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Thrombolytic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Thrombolytic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Thrombolytic Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Thrombolytic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Thrombolytic Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Thrombolytic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Thrombolytic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Thrombolytic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Thrombolytic Drug Product
Table 64. Roche Revenue in Thrombolytic Drug Business (2016-2021) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Sedico Pharmaceuticals Company Details
Table 67. Sedico Pharmaceuticals Business Overview
Table 68. Sedico Pharmaceuticals Thrombolytic Drug Product
Table 69. Sedico Pharmaceuticals Revenue in Thrombolytic Drug Business (2016-2021) & (US$ Million)
Table 70. Sedico Pharmaceuticals Recent Development
Table 71. Eumedica Company Details
Table 72. Eumedica Business Overview
Table 73. Eumedica Thrombolytic Drug Product
Table 74. Eumedica Revenue in Thrombolytic Drug Business (2016-2021) & (US$ Million)
Table 75. Eumedica Recent Development
Table 76. Genentech Company Details
Table 77. Genentech Business Overview
Table 78. Genentech Thrombolytic Drug Product
Table 79. Genentech Revenue in Thrombolytic Drug Business (2016-2021) & (US$ Million)
Table 80. Genentech Recent Development
Table 81. Microbix Company Details
Table 82. Microbix Business Overview
Table 83. Microbix Thrombolytic Drug Product
Table 84. Microbix Revenue in Thrombolytic Drug Business (2016-2021) & (US$ Million)
Table 85. Microbix Recent Development
Table 86. Medac Company Details
Table 87. Medac Business Overview
Table 88. Medac Thrombolytic Drug Product
Table 89. Medac Revenue in Thrombolytic Drug Business (2016-2021) & (US$ Million)
Table 90. Medac Recent Development
Table 91. Mochida Pharmaceutical Company Details
Table 92. Mochida Pharmaceutical Business Overview
Table 93. Mochida Pharmaceutical Thrombolytic Drug Product
Table 94. Mochida Pharmaceutical Revenue in Thrombolytic Drug Business (2016-2021) & (US$ Million)
Table 95. Mochida Pharmaceutical Recent Development
Table 96. Taj Pharmaceuticals Company Details
Table 97. Taj Pharmaceuticals Business Overview
Table 98. Taj Pharmaceuticals Revenue in Thrombolytic Drug Business (2016-2021) & (US$ Million)
Table 99. Taj Pharmaceuticals Recent Development
Table 100. Wulfing Pharma GmbH Company Details
Table 101. Wulfing Pharma GmbH Business Overview
Table 102. Wulfing Pharma GmbH Thrombolytic Drug Product
Table 103. Wulfing Pharma GmbH Revenue in Thrombolytic Drug Business (2016-2021) & (US$ Million)
Table 104. Wulfing Pharma GmbH Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Thrombolytic Drug Market Share by Type: 2020 VS 2027
Figure 2. Fibrin Specific Drugs Features
Figure 3. Nonfibrin-specific Drugs Features
Figure 4. Global Thrombolytic Drug Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Electronic Pharmacy Case Studies
Figure 8. Thrombolytic Drug Report Years Considered
Figure 9. Global Thrombolytic Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Thrombolytic Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Thrombolytic Drug Market Share by Regions: 2020 VS 2027
Figure 12. Global Thrombolytic Drug Market Share by Regions (2022-2027)
Figure 13. Global Thrombolytic Drug Market Share by Players in 2020
Figure 14. Global Top Thrombolytic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thrombolytic Drug as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Thrombolytic Drug Revenue in 2020
Figure 16. Global Thrombolytic Drug Revenue Market Share by Type (2016-2021)
Figure 17. Global Thrombolytic Drug Revenue Market Share by Type (2022-2027)
Figure 18. North America Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Thrombolytic Drug Market Share by Type (2016-2027)
Figure 20. North America Thrombolytic Drug Market Share by Application (2016-2027)
Figure 21. North America Thrombolytic Drug Market Share by Country (2016-2027)
Figure 22. United States Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Thrombolytic Drug Market Share by Type (2016-2027)
Figure 26. Europe Thrombolytic Drug Market Share by Application (2016-2027)
Figure 27. Europe Thrombolytic Drug Market Share by Country (2016-2027)
Figure 28. Germany Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Thrombolytic Drug Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Thrombolytic Drug Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Thrombolytic Drug Market Share by Region (2016-2027)
Figure 38. China Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Thrombolytic Drug Market Share by Type (2016-2027)
Figure 46. Latin America Thrombolytic Drug Market Share by Application (2016-2027)
Figure 47. Latin America Thrombolytic Drug Market Share by Country (2016-2027)
Figure 48. Mexico Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Thrombolytic Drug Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Thrombolytic Drug Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Thrombolytic Drug Market Share by Country (2016-2027)
Figure 54. Turkey Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Thrombolytic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Roche Revenue Growth Rate in Thrombolytic Drug Business (2016-2021)
Figure 58. Sedico Pharmaceuticals Revenue Growth Rate in Thrombolytic Drug Business (2016-2021)
Figure 59. Eumedica Revenue Growth Rate in Thrombolytic Drug Business (2016-2021)
Figure 60. Genentech Revenue Growth Rate in Thrombolytic Drug Business (2016-2021)
Figure 61. Microbix Revenue Growth Rate in Thrombolytic Drug Business (2016-2021)
Figure 62. Medac Revenue Growth Rate in Thrombolytic Drug Business (2016-2021)
Figure 63. Mochida Pharmaceutical Revenue Growth Rate in Thrombolytic Drug Business (2016-2021)
Figure 64. Taj Pharmaceuticals Revenue Growth Rate in Thrombolytic Drug Business (2016-2021)
Figure 65. Wulfing Pharma GmbH Revenue Growth Rate in Thrombolytic Drug Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
血栓溶解薬のグローバル市場：規模・現状・予測2019-2025 Thrombolytic drugs, which dissolve solid blood clots, are commonly used to treat clot complications such as acute myocardial infarction, pulmonary embolism, deep venous thrombosis, blocked catheters, and acute ischemic stroke.Urokinase, streptokinase and tissue plasminogen activator (tPA) are the ba…- 血栓溶解薬のグローバル市場：規模・現状・予測2019-2025 Thrombolytic drugs, which dissolve solid blood clots, are commonly used to treat clot complications such as acute myocardial infarction, pulmonary embolism, deep venous thrombosis, blocked catheters, and acute ischemic stroke.Urokinase, streptokinase and tissue plasminogen activator (tPA) are the ba…
- 血栓溶解療法のグローバル市場：規模・現状・予測2019-2025 Blood clots are one of the most serious complications in the body.When blood clots, major arteries or veins become blocked, which stops normal blood flow.The cessation of normal blood flow can cause bleeding and often leads to heart attacks and strokes.Thrombolytic therapy is a treatment in which so…
- 血栓溶解療法のグローバル市場：規模・現状・予測2019-2025 Blood clots are one of the most serious complications in the body.When blood clots, major arteries or veins become blocked, which stops normal blood flow.The cessation of normal blood flow can cause bleeding and often leads to heart attacks and strokes.Thrombolytic therapy is a treatment in which so…
- 世界の抗コリン薬市場規模・現状・予測（2021年-2027年） Anticholinergic drugs are used to restrict the acetylcholine-provoked neurotransmission in different parts of the body including heart, peripheral nervous system, and other parts. Acetylcholine controls the involuntary functions such as salivation, sweating, digestion, and several others. The drug i…